W. Gregory Sawyer

Moffitt Cancer Center Chief BioEngineering Officer, @MoffittNews. Cancer Engineer, Tribologist, Survivor, and Chair of #BioEngineering. Views are my own.

[W. Gregory Sawyer @ProfGregSawyer]

Great chat with @PatrickHwuMD at #ASCO26!

[Dr. Patrick Hwu @PatrickHwuMD]

Live from #ASCO26, I spoke with Dr. Greg Sawyer (@ProfGregSawyer), Chair of Bioengineering @MoffittNews, about the latest in cancer engineering, novel research models and precision medicine.

It’s exciting to see how engineering is helping drive new ideas in cancer therapeutics and improve the way scientists study cancer. #ASCO26 #MoffittASCO26

[W. Gregory Sawyer @ProfGregSawyer]

Want to learn more about what we are doing in the Department of BioEngineering at @MoffittNews? Stop by booth #14012 today at #ASCO26!

[Dr. Patrick Hwu @PatrickHwuMD]

I caught up with Dr. Nikhil Khushalani of @Moffittnews about his work in melanoma and other skin cancers.

His research focuses on developing new treatment options for patients with melanoma, including uveal melanoma and melanoma that has spread to the brain.
#ASCO26 #MoffittASCO26

[Moffitt Cancer Center @MoffittNews]

Have you visited our booth at #ASCO26 yet? Don’t miss the chance to connect with Moffitt experts and see how we are advancing cancer research.

📍Booth #14012
#MoffittASCO26

[Moffitt Cancer Center @MoffittNews]

At #ASCO26, Karun Neupane, MD (@KarunNeupaneMD), and Jeff Johnson, MD, joined @PatrickHwuMD to discuss receiving prestigious Young Investigator Awards from @ConquerCancerFd. Their funded research focuses on AI-guided treatment optimization in multiple myeloma and ctDNA-guided decision-making in penile squamous cell carcinoma. Congratulations to these outstanding early-career investigators advancing the future of cancer care. #MoffittASCO26

[W. Gregory Sawyer @ProfGregSawyer]

Ready for day 3 of #ASCO26!

[Moffitt Cancer Center @MoffittNews]

Day 3 of #ASCO26 is here! Join Moffitt experts as they share the latest advances in cancer research and care. Stop by booth #14012 to connect with our team and explore a full list of presentations at https://t.co/BK9OdLjCMd. #MoffittASCO26

[Moffitt Cancer Center @MoffittNews]

https://t.co/ig7DCxK2DS

[Moffitt Cancer Center @MoffittNews]

Thank you to everyone who joined us for our #ASCO26 reception. It was a great opportunity to connect with colleagues and industry partners while celebrating the impactful research and innovation presented by Moffitt experts. We’re proud to be part of the work advancing cancer care and improving outcomes for patients worldwide. #MoffittASCO26

[Dr. Patrick Hwu @PatrickHwuMD]

Honored to gather with our Moffitt team, partners and supporters at this year’s @MoffittNews #ASCO26 reception!

We’re grateful for everyone helping drive progress in cancer care and clinical research. Special thanks to our sponsors Johnson & Johnson, Iovance, and Nuvalent. #MoffittASCO26

@JNJNews @IovanceBio @nuvalent

[W. Gregory Sawyer @ProfGregSawyer]

Check out @MoffittNews while at #ASCO26!

[Moffitt Cancer Center @MoffittNews]

We're not finished until cancer is.

Stop by our booth at #ASCO26 to meet our experts and see the impact Moffitt is making in cancer research. Researchers are presenting cutting edge advances in the areas of immunotherapy, artificial intelligence, radiation therapy, triplet therapy and more.

Explore the full list of presentations: https://t.co/YQ4nD3kGdI
#MoffittASCO26

[Dr. Patrick Hwu @PatrickHwuMD]

Live from #ASCO26, I spoke with Dr. Kumar Karyampudi about @MoffittNews' work in cell therapies.

Through Moffitt’s unique research and clinical ecosystem, teams are helping move cell therapy approaches from the lab to the clinic and expand access to novel treatments for patients.
#ASCO26 #MoffittASCO26

[Moffitt Cancer Center @MoffittNews]

At #ASCO26, Physician in Chief Karen Lu, MD (@karenluMD), and Andreas Saltos, MD, discuss emerging lung cancer data, including phase 3 results evaluating immunotherapy combined with a TROP2-targeting antibody-drug conjugate in frontline non-small cell lung cancer. He also shares updates on his ongoing research in treatment-resistant disease. #MoffittASCO26

[Moffitt Cancer Center @MoffittNews]

We caught up with Karen Lu, MD (@karenluMD), and Monica Avila, MD (@MAvilaMD), at the #MoffittASCO26 booth to discuss exciting developments in gynecologic cancers, from encouraging survival data in uterine cancer to emerging targeted therapies and antibody-drug conjugates that may help shape future treatment options for patients. #ASCO26

[Moffitt Cancer Center @MoffittNews]

🚨New Results: Moffitt’s Andrew Kuykendall, MD (@KuykendallMd), discusses the SENTRY study presented at #ASCO26 evaluating selinexor plus ruxolitinib in patients with myelofibrosis.

Reviewing data from @IcahnMountSinai and John Mascarenhas, MD, he highlights how the study goes beyond the standard of care, including a potential early survival benefit that warrants further study. #MoffittASCO26

[Moffitt Cancer Center @MoffittNews]

From identifying distress to connecting caregivers with support, Christine Vinci, PhD, shares research at #ASCO26 exploring how a simple screening tool may help recognize caregivers who need additional resources while supporting patients undergoing hematopoietic stem cell transplant. #MoffittASCO26

[Dr. Patrick Hwu @PatrickHwuMD]

Live from #ASCO26, I spoke with Dr. Vernon Sondak (@VernSondakMD) of @Moffittnews, about his work advancing melanoma research and treatment.

As chair of Moffitt’s Department of Cutaneous Oncology, Dr. Sondak has helped build one of the world’s leading multidisciplinary programs for melanoma and related skin cancers.
#ASCO26 #MoffittASCO26

[Dr. Patrick Hwu @PatrickHwuMD]

While at #ASCO26, I spoke with Dr. Andrew Kuykendall (@KuykendallMd), assistant member in Malignant Hematology at @Moffittnews, about his work advancing research and treatment for rare blood cancers.

His research focuses on finding new treatment options for patients with myeloproliferative neoplasms, MDS/MPN overlap syndromes and systemic mastocytosis. #ASCO26 #MoffittASCO26

[Dr. Patrick Hwu @PatrickHwuMD]

While at #ASCO26, I spoke with Dr. Monica Avila (@MAvilaMD), gynecologic oncologist @Moffittnews, about her work advancing care for patients with gynecologic malignancies.

Dr. Avila specializes in complex surgical approaches, including minimally invasive techniques, and has a strong interest in HPV-driven malignancies. #ASCO26 #MoffittASCO26

[Dr. Patrick Hwu @PatrickHwuMD]

From the booth at #ASCO26, I spoke with Dr. Marilyn Bui of @Moffittnews, about her work in pathology, biomarker testing and AI.

Her expertise in digital pathology and augmented intelligence is helping support more precise cancer diagnosis and treatment planning for patients.
#ASCO26 #MoffittASCO26

[Moffitt Cancer Center @MoffittNews]

During #ASCO26, Martine Extermann, MD, PhD, shares research examining genetic associations with chemotherapy-induced nausea and vomiting and insights that may help advance supportive cancer care. #MoffittASCO26